Trial Profile
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2022
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Alcohol-related disorders
- Focus Therapeutic Use
- Acronyms TOP G
- 23 Mar 2020 Status changed from active, no longer recruiting to completed.
- 12 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 04 Oct 2017 Planned End Date changed from 1 Jan 2020 to 1 Jan 2021.